Picture of Precigen logo

PGEN — Precigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Precigen Inc reports results for the quarter ended in March - Earnings Summary

* Precigen Inc  PGEN.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss of 9
cents per share.
    * Revenue fell 94.2% to $1.85 million from a year ago;
analysts
expected $2.23 million. 
    * Precigen Inc's reported EPS for the quarter was a loss
of 10
cents​.
    * The mean earnings estimate of analysts had risen by
about 11% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Precigen Inc shares had risen by 18.9% this quarter and
lost 17.1% so far this year.
    * The company reported a quarterly loss of $22.73 million.
    * Wall Street's median 12-month price target for Precigen
Inc is
$8.15 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 01:25 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.09          -0.10          Missed
 Dec. 31 2022      -0.10          -0.11          Missed
 Sep. 30 2022      0.02           -0.04          Missed
 Jun. 30 2022      -0.13          -0.09          Beat

Recent news on Precigen

See all news